Stapp Wealth Management, P »

Crispr Therapeutics shares owned by Stapp Wealth Management, P

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Stapp Wealth Management, P from 13F filings

Historical chart of Stapp Wealth Management, P investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Stapp Wealth Management, P consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Stapp Wealth Management, P

Quarter filed Position value Share count Share price at filing
2024-03-31 $235k 3.5k 68.16
2023-12-31 $216k 3.5k 62.60
2022-09-30 $181k 2.8k 65.20

More positions owned by Stapp Wealth Management, P

Wisdomtree Tr Floatng Rat Trea (USFR)
Ssga Active Etf Tr Spdr Tr Tactic (TOTL)
World Gold Tr Spdr Gld Minis (GLDM)
Abrdn Gold Etf Trust Physcl Gold Shs (SGOL)
Tidal Tr Ii Blueprint Chesap (TFPN)
Simplify Exchange Traded Fun Intmd Term Trsry (TYA)
Vanguard World Financials Etf (VFH)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard World Comm Srvc Etf (VOX)
Vanguard World Utilities Etf (VPU)
Vanguard World Health Car Etf (VHT)
Occidental Petroleum Corporation (OXY)
Spdr Ser Tr Aerospace Def (XAR)
Ishares Silver Tr Ishares (SLV)
Spdr Ser Tr Bloomberg 3-12 M (BILS)

View all positions for Stapp Wealth Management, P

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics